Hinge Health, Inc. Cash Flow Statement
HNGE / Information Technology|3 years of annual SEC 10-K data (FY2023-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
Hinge Health, Inc. generated $171M in operating cash flow and $171M in free cash flow in FY2025. Free cash flow margin was 29.0% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income | -$528.3M | -$11.9M | -$108.1M |
| Depreciation & Amortization | $5.1M | $6.0M | $5.6M |
| Operating Cash Flow | $171.4M | $49.0M | -$63.9M |
| Capital Expenditures | $708.0K | $1.0M | $2.0M |
| Free Cash Flow | $170.7M | $48.0M | -$65.9M |
| Share Buybacks | $65.0M | $0 | $0 |
| FCF Margin | 29.0% | 12.3% | -22.5% |